Manolo Bellotto
Corporate Officer/Principal en GAIN THERAPEUTICS, INC. .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Matthias Alder | M | 59 |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 3 años |
| Jeffrey Riley | M | 61 |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 5 años |
| Khalid Islam | M | 67 |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 7 años |
| Gianluca Fuggetta | M | 35 | 2 años | |
| Dov Goldstein | M | 56 | 3 años | |
| Eric Richman | M | 63 | 4 años | |
| Gwen Melincoff | M | 72 | 3 años | |
| Hans-Peter Hasler | M | 68 | 3 años | |
| Claude Nicaise | M | 71 | 3 años | |
| Elena Cubero-Jorda | F | - | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Charles Ballantyne | M | 64 | 1 años | |
| Robert Peugeot | M | 74 | 11 años | |
| Rainer-Marc Frey | M | 61 | 10 años | |
| Salvatore Calabrese | M | 54 | 3 años | |
| Lorenzo Leoni | M | - | 4 años | |
| Roberto de Ponti | M | - |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 1 años |
| Roberto Barzi | M | 48 | 2 años | |
| Somboon Prasitjutrakul | M | 65 | - | |
| Charles Toomey | M | 62 | - | |
| Kevin Doyle Corning | M | - | 4 años | |
| Xavier Barril | M | - | 6 años | |
| Marianne Bjordal | M | - | 1 años | |
| Ana Maria Garcia-Collazo | M | - | - |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 17 | 73.91% |
| Suiza | 9 | 39.13% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Manolo Bellotto
- Red Personal
